Latest Insider Transactions at Predictive Oncology Inc. (POAI)
This section provides a real-time view of insider transactions for Predictive Oncology Inc. (POAI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Predictive Oncology Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Predictive Oncology Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 05
2024
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,353
+9.97%
|
-
|
|
Apr 05
2024
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,353
+11.2%
|
-
|
|
Apr 05
2024
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,268
+9.29%
|
-
|
|
Apr 05
2024
|
Veena Rao Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,268
+26.39%
|
-
|
|
Apr 05
2024
|
Matthew Hawryluk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,368
+19.97%
|
-
|
|
Apr 05
2024
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,268
+12.67%
|
-
|
|
Oct 02
2023
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+9.47%
|
-
|
|
Oct 02
2023
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+11.34%
|
-
|
|
Oct 02
2023
|
Veena Rao Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+24.28%
|
-
|
|
Oct 02
2023
|
Matthew Hawryluk Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+20.81%
|
-
|
|
Oct 02
2023
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+9.95%
|
-
|
|
Oct 02
2023
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+8.91%
|
-
|
|
Sep 25
2023
|
Robert L Myers CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-9.75%
|
$1,020
$2.96 P/Share
|
|
Sep 25
2023
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+24.17%
|
-
|
|
Sep 25
2023
|
Charles Lee Sr Nuzum Director |
SELL
Open market or private sale
|
Direct |
10,000
-29.38%
|
$30,000
$3.04 P/Share
|
|
Jul 03
2023
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,773
+19.02%
|
-
|
|
Jul 03
2023
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,773
+9.98%
|
-
|
|
Jul 03
2023
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+15.06%
|
-
|
|
Jul 03
2023
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+17.3%
|
-
|
|
Jul 03
2023
|
Matthew Hawryluk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+33.71%
|
-
|
|
Jul 03
2023
|
Veena Rao Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,675
+40.23%
|
-
|
|
May 12
2023
|
Veena Rao Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,299
+50.0%
|
-
|
|
Apr 03
2023
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+8.32%
|
-
|
|
Apr 03
2023
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+6.89%
|
-
|
|
Apr 03
2023
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,499
+9.4%
|
-
|
|
Apr 03
2023
|
Matthew Hawryluk Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+26.21%
|
-
|
|
Apr 03
2023
|
David Stewart Smith |
BUY
Grant, award, or other acquisition
|
Direct |
18,360
+14.41%
|
-
|
|
Apr 03
2023
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,499
+4.04%
|
-
|
|
Jan 25
2023
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,539
+8.45%
|
-
|
|
Jan 03
2023
|
David Stewart Smith |
BUY
Grant, award, or other acquisition
|
Direct |
71,755
+44.18%
|
-
|
|
Jan 03
2023
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
172,150
+24.65%
|
-
|
|
Jan 03
2023
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
97,848
+29.86%
|
-
|
|
Jan 03
2023
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
99,664
+31.16%
|
-
|
|
Jan 03
2023
|
Matthew Hawryluk Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,570
+36.99%
|
-
|
|
Jan 03
2023
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
58,708
+29.19%
|
-
|
|
Jan 03
2023
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
63,422
+25.64%
|
-
|
|
Dec 15
2022
|
Daniel E Handley Director |
BUY
Open market or private purchase
|
Direct |
6,000
+4.74%
|
$0
$0.41 P/Share
|
|
Dec 02
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
5,000
+2.85%
|
$0
$0.52 P/Share
|
|
Dec 02
2022
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
8,795
+10.99%
|
$0
$0.57 P/Share
|
|
Dec 01
2022
|
Matthew Hawryluk Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,762
+50.0%
|
-
|
|
Nov 29
2022
|
Daniel E Handley Director |
BUY
Open market or private purchase
|
Direct |
10,000
+8.03%
|
$0
$0.36 P/Share
|
|
Nov 01
2022
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
213,300
+33.86%
|
-
|
|
Oct 25
2022
|
David Stewart Smith |
BUY
Grant, award, or other acquisition
|
Direct |
18,911
+50.0%
|
-
|
|
Oct 03
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
16,667
+17.47%
|
-
|
|
Oct 03
2022
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,147
+16.11%
|
-
|
|
Oct 03
2022
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,147
+6.14%
|
-
|
|
Oct 03
2022
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,147
+18.13%
|
-
|
|
Oct 03
2022
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,147
+14.92%
|
-
|
|
Sep 23
2022
|
Robert L Myers CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,199
-14.03%
|
$0
$0.39 P/Share
|
|
Sep 23
2022
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+31.45%
|
-
|